Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Geoffrey C. Li has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protein-enhanced small molecule disruptors of ordered membrane domains

    by Katherine M. Stefanski, Geoffrey C. Li, Dustin D. Luu, Kelvin K. Fosu, Eduardo Guadarrama, James M. Hutchison, Nilabh Saksena, Yelyzaveta Zuy, Alexander J. Fisch, Thomas P. Hasaka, et al.

    Membrane order and fluidity influence many biological processes. However, tools to manipulate membranes under physiological conditions have been limited. In the process of high-throughput screening for molecules that shift the phase partitioning between ordered and disordered membrane phases of the tetraspan membrane protein peripheral myelin protein 22 (PMP22), we identified two chemically similar compounds, VU0615562 and VU0619195, that shift PMP22 toward the disordered phase and destabilize the “lipid raft”-like ordered phase. Follow-up experiments showed that this latter activity is, counterintuitively, enhanced by the presence of PMP22, which normally stabilizes the ordered phase. Biophysical studies indicate that these compounds reduce raft stability through a mechanism that involves both direct interactions with proteins and the disruption of lipid packing. We further observed that acute treatment of live cells with VU0619195 modulated membrane fluidity and TRPM8 channel function while both compounds altered KCNQ1 channel activity, providing examples of practical applications for these compounds. These protein-enhanced raft modulators reveal distinct lipid and protein-based forces that destabilize membrane order and may be useful as pharmacological tools for manipulating and probing the biological roles of ordered membrane domains in cells.

  • Open Access

    Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease

    by Charles R. Sanders, Bruce D. Carter, Mason C. Wilkinson, Geoffrey C. Li, Katherine M. Stefanski

    Charcot-Marie-Tooth disease (CMT) is an often-debilitating peripheral neuropathy that is a top-10 most prevalent human genetic disorder. However, there is currently no effective treatment. Over half of diagnosed CMT cases in western populations are caused by genetic variations that alter the expression levels or sequence of peripheral myelin protein 22 (PMP22). PMP22 is a tetraspan membrane glycoprotein that is most highly expressed in Schwann cells (SCs) of the peripheral nervous system (PNS) under conditions of myelination, where it plays multiple important roles. These functions are reduced in humans with only a single PMP22 allele, resulting in a common and usually mild form of CMT, hereditary neuropathy with liability to pressure palsies (HNPP). The rare type 1E CMT (CMT1E) is caused by amino acid variations in PMP22. The most common form of CMT (CMT1A) is caused by a third wild type (WT) allele of PMP22. The disease mechanisms of CMT1A are still incompletely understood, but there is much evidence that a major driver is proteostasis stress caused by WT PMP22 overexpression upon induction of myelination in SCs, possibly compounded by gain-of-function effects. Here, we explore PMP22's structure, functions, trafficking, role in CMT, and prospects for successful therapeutic intervention.


  • Open Access

    Pharmacological tools to modulate ordered membrane domains and order-dependent protein function

    by Katherine M. Stefanski, Hui Huang, Dustin D. Luu, Geoffrey C. Li, James M. Hutchison, Nilabh Saksena, Alexander J. Fisch, Thomas P. Hasaka, Joshua A. Bauer, Anne K. Kenworthy, et al.

    Ordered membrane nanodomains colloquially known as “lipid rafts” have many proposed cellular functions. However, pharmacological tools to modulate protein affinity for rafts and to manipulate raft formation are currently lacking. We screened 24,000 small molecules for compounds that impact the raft affinity of a known raft-preferring model protein, peripheral myelin protein 22 (PMP22), in giant plasma membrane vesicles (GPMVs). Hits were tested against another model raft protein, MAL, and also tested for their impact on raft stability. We identified three chemically distinct tools for manipulating lipid rafts. Two compounds were found to destabilize ordered domains (VU0607402 and VU0519975) while a third (primaquine diphosphate) increased PMP22 partitioning and stabilized ordered domains. While discovered in a PMP22-focused screen, all three were seen to modulate raft formation in a protein-independent manner by altering lipid-lipid interactions and membrane fluidity. Acute treatment of live cells with the raft destabilizing compound, VU0607402 was seen to modulate TRPM8 channel function, highlighting the utility of this compound in live-cell experiments for dissecting the role that membrane order and fluidity play in cell signaling. These compounds provide pharmacological tools for probing lipid raft properties and function in biophysical experiments and in living cells.


  • Open Access

    Water-Soluble Integral Membrane Protein Nanoparticles

    by Ricardo Capone, James Hutchison, Amanda Cao, Geoffrey Li, James Hayes, Oliver Chalkley, Michael Goodman, Manuel Castro, William Weeks, Sivaraja Vaithiyalingam, et al.

    Helical integral membrane proteins are assumed to require a lipid bilayer or model membrane (e.g. detergent micelles) to prevent aggregation and precipitation in aqueous solution. Here, we show that this is not always true and that single-span helical integral membrane proteins are capable of forming stable but reversible protein nanoparticle assemblies (detergent-limited particles — DLPs) when purified after removal of lipid and all or nearly all detergent. Residual detergent in DLPs is not exchangeable with the surrounding solution. This work focuses on DLPs formed by the transmembrane C-terminal domain of the human amyloid precursor protein (C99), although evidence of DLP formation by other membrane proteins is provided. Size exclusion chromatography, light scattering and electron microscopy showed that C99-DLPs are spherical with modest polydispersity (7-16 monomers) and are stable for months in solution. C99-DLPs revert to traditional protein-detergent complexes upon addition of detergent. Circular dichroism and 2D IR spectroscopies revealed that β-sheet content is significantly higher in C99-DLPs than that of C99 in detergent micelles. C99-DLPs were taken up by mammalian cells, trafficked to a perinuclear location and appeared to accumulate in or next to LC3B-positive punctae, which likely are stalled autophagosomes. C99-DLPs appeared to remain intact in cells as there was no evidence of protein degradation over a period of days. This work challenges the broad assumption that native single-span membrane proteins always require either a bilayer or membrane mimetic to prevent aggregation / precipitation from solutions. It also shows that protein nanoparticles are not always easily degraded by cellular proteases.

  • Open Access

    How T118M peripheral myelin protein 22 predisposes humans to Charcot–Marie–Tooth disease

    by Katherine M. Stefanski, Geoffrey C. Li, Justin T. Marinko, Bruce D. Carter, David C. Samuels, Charles R. Sanders


  • Open Access

    ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy

    by Cristina Olivieri, Geoffrey C. Li, Yingjie Wang, Manu V.S., Caitlin Walker, Jonggul Kim, Carlo Camilloni, Alfonso De Simone, Michele Vendruscolo, David A. Bernlohr, et al.

    ATP-competitive inhibitors are currently the largest class of clinically approved drugs for protein kinases. By targeting the ATP-binding pocket, these compounds block the catalytic activity, preventing substrate phosphorylation. A problem with these drugs, however, is that inhibited kinases may still recognize and bind downstream substrates, acting as scaffolds or binding hubs for signaling partners. Here, using protein kinase A as a model system, we show that chemically different ATP-competitive inhibitors modulate the substrate binding cooperativity by tuning the conformational entropy of the kinase and shifting the populations of its conformationally excited states. Since we found that binding cooperativity and conformational entropy of the enzyme are correlated, we propose a new paradigm for the discovery of ATP-competitive inhibitors, which is based on their ability to modulate the allosteric coupling between nucleotide and substrate-binding sites.


  • Ion mobility–mass spectrometry reveals the role of peripheral myelin protein dimers in peripheral neuropathy

    by Sarah M. Fantin, Kristine F. Parson, Pramod Yadav, Brock Juliano, Geoffrey C. Li, Charles R. Sanders, Melanie D. Ohi, Brandon T. Ruotolo

    Significance: The myelin sheath surrounding human neurons acts as insulation and increases their rate of signal transmission. Peripheral myelin protein (PMP22) is a key transmembrane protein involved in neuron myelination, the dysfunction of which can lead to significant human neuropathies. This report provides direct evidence that disease-associated PMP22 mutants are unstable and can self-associate to form dimers to a greater extent than wild-type protein, providing mechanistic insight into diseases such as Charcot-Marie-Tooth and Dejerine–Sottas syndrome. To accomplish this, we link mass-selected gas-phase protein stability measurements to in vivo protein trafficking data, paving the way for the future use of such data in understanding such complex biochemical processes.


  • Open Access

    Multi-state recognition pathway of the intrinsically disordered protein kinase inhibitor by protein kinase A

    by Cristina Olivieri, Yingjie Wang, Geoffrey C Li, Manu V S, Jonggul Kim, Benjamin R Stultz, Matthew Neibergall, Fernando Porcelli, Joseph M Muretta, David Dt Thomas, et al.

    In the nucleus, the spatiotemporal regulation of the catalytic subunit of cAMP-dependent protein kinase A (PKA-C) is orchestrated by an intrinsically disordered protein kinase inhibitor, PKI, which recruits the CRM1/RanGTP nuclear exporting complex. How the PKA-C/PKI complex assembles and recognizes CRM1/RanGTP is not well understood. Using NMR, SAXS, fluorescence, metadynamics, and Markov model analysis, we determined the multi-state recognition pathway for PKI. After a fast binding step in which PKA-C selects PKI’s most competent conformations, PKI folds upon binding through a slow conformational rearrangement within the enzyme’s binding pocket. The high-affinity and pseudo-substrate regions of PKI become more structured and the transient interactions with the kinase augment the helical content of the nuclear export sequence, which is then poised to recruit the CRM1/RanGTP complex for nuclear translocation. The multistate binding mechanism featured by PKA-C/PKI complex represents a paradigm on how disordered, ancillary proteins (or protein domains) are able to operate multiple functions such as inhibiting the kinase while recruiting other regulatory proteins for nuclear export.


  • Open Access

    Peripheral Myelin Protein 22 Preferentially Partitions into Ordered Phase Membrane Domains

    by Justin T. Marinko, Geoffrey C. Li, Anne K. Kenworthy, Charles R. Sanders

    The ordered environment of membrane rafts is thought to exclude many transmembrane proteins. Nevertheless, some multi-pass transmembrane proteins have been proposed to partition into ordered domains. Here, giant plasma membrane vesicles (GPMVs) were employed to quantitatively show that the tetraspan peripheral myelin protein 22 (PMP22) exhibits a pronounced preference for, promotes the formation of, and stabilizes ordered membrane domains. Neither S-palmitoylation of PMP22 nor its putative cholesterol binding motifs are required for partitioning to ordered domains. In contrast, disruption of its unusual first transmembrane helix (TM1) reduced ordered phase preference. Charcot-Marie-Tooth disease-causing mutations that destabilize PMP22 also reduced or eliminated this preference in favor of the disordered phase. These studies demonstrate PMP22’s ordered phase preference derives both from the distinctive properties of TM1 and global structural features associated with its transmembrane domain, providing a first glimpse at the structural factors that promote raft partitioning for multi-pass proteins.Significance Statement: The preferential partitioning of single span membrane proteins for the ordered phase of ordered/disordered phase-separated membranes is now reasonably well understood, but little is known about this phase preferences of multi-pass membrane proteins. Here, it is shown that the disease-linked tetraspan integral membrane protein, PMP22, displays a pronounced preference to partition into the ordered phase, a preference that is reversed by disease mutations. This phase preference may be related to the role of PMP22 in cholesterol homeostasis in myelinating Schwann cells, a role that is also known to be disrupted under conditions of CMTD peripheral neuropathy caused bypmp22mutations.


  • Genetic intolerance analysis as a tool for protein science

    by Geoffrey C. Li, Eliot T.C. Forster-Benson, Charles R. Sanders